that bs-Ab (TNF-α × CEA) against carcinoembryonic (CEA) and TNF-α enhances radiotherapy both in vivo and in vitro of colon cancer, particularly in tumors that overexpress CEA [320]. The gene discussed is TNF; the disease is malignant colon neoplasm.